Novavax rises as biotech rally spreads after Merck-Moderna data
Novavax shares are trading higher Wednesday as a broad biotech rally follows Merck and Moderna Phase 3 INTerpath-001 melanoma results; no Novavax-specific catalyst was supplied.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.